IPP Bureau
Nanavati Max Hospital performs 4-hour simultaneous pancreas-kidney transplant on 25-year-old with Type-1 diabetes
By IPP Bureau - August 26, 2025
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Roche’s US subsidiary Genentech breaks ground on $700 million manufacturing facility in North Carolina
By IPP Bureau - August 26, 2025
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
J&J to invest $2 billion at CDMO Fujifilm’s new hub
By IPP Bureau - August 25, 2025
Investment supports Company’s plans to manufacture the vast majority of advanced medicines in the U.S. to meet the needs of patients in the U.S.
Parexel appoints Jim Anthony as CCO and President, Parexel Biotech
By IPP Bureau - August 25, 2025
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Enanta files patent infringement suit against Pfizer
By IPP Bureau - August 25, 2025
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Boehringer and AnGes sign manufacturing agreement for HGF gene therapy product
By IPP Bureau - August 25, 2025
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
FDA grants ODD to Keros KER-065 for treatment of Duchenne muscular dystrophy
By IPP Bureau - August 25, 2025
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
Eris Lifesciences receives ANVISA approval at its Ahmedabad campus
By IPP Bureau - August 25, 2025
GSK forays into oncology in India with Jemperli and Zejula
By IPP Bureau - August 25, 2025
The company is bringing precision therapies for gynaecological cancers
Briefs: Mankind Pharma, Mangalam Drugs and Organics, Veerhealth Care and Shelter Pharma
By IPP Bureau - August 25, 2025
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
Akums Drugs and Pharmaceuticals signs framework agreement with Govt. of Zambia
By IPP Bureau - August 24, 2025
This project shall be implemented through incorporation of a new joint venture company in Zambia
FDA approved Dawnzera in US as first and only RNA-targeted prophylactic treatment for hereditary angioedema
By IPP Bureau - August 24, 2025
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Corbion and Kuehnle join forces to develop natural Astaxanthin from algae fermentation
By IPP Bureau - August 23, 2025
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
Star Health Insurance settles claims of Rs.11,500 Cr
By IPP Bureau - August 23, 2025
The company has improved access to quality healthcare for seniors across both urban and rural areas
Moderna receives Health Canada approval for updated COVID-19 vaccine targeting SARS-CoV-2 Variant LP.8.1
By IPP Bureau - August 23, 2025
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
